象鼻术后开放胸腹主动脉瘤修复的围术期与远期结局
回顾性多中心研究纳入32例既往行主动脉弓修复(含象鼻或冰冻象鼻)后接受开放胸腹主动脉瘤修复的患者,院内死亡率为18.75%,1年生存率为78.1%(95%CI 63.9%-95.6%),随访期间无手术相关再干预,主动脉相关死亡1例。
要点
- 既往弓部修复含象鼻术后开放TAAA修复院内死亡率为18.75%。
- 术后脊髓缺血2例,其中1例永久性截瘫;暂时性急性肾损伤发生率为41.94%。
- 估计1年生存率为78.1%(95%CI 63.9%-95.6%),随访期无手术相关再干预。
核心结论
- 既往因急性或慢性主动脉病变行含象鼻或冰冻象鼻的主动脉弓修复后,开放胸腹主动脉瘤修复伴有显著的围术期并发症发生率和死亡率。
- 随访期间主动脉相关死亡率和手术相关再干预率较低。
研究设计与样本
- 回顾性、观察性、多中心研究,纳入2006年至2019年两家主动脉中心采用相同手术方案治疗的32例患者。
- 评估围术期和远期结局,包括院内并发症和死亡率、手术相关再干预率及主动脉相关死亡率,采用Kaplan-Meier曲线分析术后总生存。
主要发现
- 32例患者平均年龄45.0±13.6岁,男性20例(62.5%),急性病变占34.38%(n=11),慢性病变占65.62%(n=21)。
- 院内死亡率为18.75%(n=6);脊髓缺血2例,均发生在一期急诊手术后,其中1例永久性截瘫;暂时性急性肾损伤发生率为41.94%(n=13)。
- 估计1年生存率为78.1%(95%CI 63.9%-95.6%),中位随访时间1.29年(四分位距0.26-3.88年)。
- 未观察到手术相关再干预,主动脉相关死亡1例,为移植物感染导致的脓毒症。
临床怎么用
- 对于既往行含象鼻或冰冻象鼻主动脉弓修复后的胸腹主动脉瘤患者,开放修复仍是一种可选策略,但需充分评估围术期风险。
- 围术期应重点关注脊髓缺血和急性肾损伤的预防与监测,尤其在一期急诊手术患者中。
- 远期随访中主动脉相关死亡和再干预率较低,但仍需监测移植物感染等并发症。
局限性
- 回顾性观察性设计,样本量较小(32例),中位随访时间较短(1.29年)。
- 仅纳入两家中心使用相同手术方案的患者,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To describe the outcome of open thoracoabdominal aortic aneurysm (TAAA) repair following previous aortic arch repair including elephant trunk (ET) or frozen elephant trunk (FET) for acute and chronic pathologies. METHODS: This was a retrospective, observational, multicenter study including 32 patients treated between 2006 and 2019 in two aortic centers using identical surgical protocols. Assessment focused on perioperative and long-term outcome, namely in-hospital morbidity and mortality, as well as procedure-related reintervention rate and aortic-related mortality rate. Kaplan-Meier curves with 95% confidence intervals were used to analyze the overall survival after surgery within the cohort. RESULTS: Thirty-two patients (mean age, 45.0 ± 13.6 years; 20 males [62.5%]) were treated because of acute (34.38% [n = 11]) or chronic (65.62% [n = 21]) aortic pathologies, including residual dissection following acute, symptomatic type A dissection (n = 7) and symptomatic mega aortic syndrome (n = 4), as well as post-dissection TAAA (n = 18) and asymptomatic mega aortic syndrome (n = 3). Twenty-eight patients (87.5%) received type II repair, and 4 patients (12.5%) received type III repair after previous ascending aorta and arch repair including ET/FET. Concomitant infrarenal and iliac vessel repair was performed in 38.7% (n = 12) and 29.4% (n = 10), respectively. The in-hospital mortality rate was 18.75% (n = 6). Spinal cord ischemia occurred in two cases, both after one-stage emergency procedure with one case of permanent paraplegia. Temporary acute kidney injury occurred in 41.94% (n = 13). The estimated 1-year survival rate was 78.1% (95% confidence interval, 63.9%-95.6%), with a median follow-up time of 1.29 years (interquartile range, 0.26-3.88 years). No procedure-related reinterventions and one case of aortic-related mortality, namely sepsis because of graft infection, was observed. CONCLUSIONS: Open TAAA repair following aortic arch repair including ET or FET because of acute or chronic aortic pathologies is associated with a relevant perioperative morbidity and mortality rate. During follow-up, a low aortic-related mortality rate and procedure-related reintervention rate were observed.
引用
- Gombert A, Ketting S, Rückbeil MV, et al. Perioperative and long-term outcome after ascending aortic and arch repair with elephant trunk and open thoracoabdominal aortic aneurysm repair. J Vasc Surg. 2021. PMID: 34606958. doi:10.1016/j.jvs.2021.09.026
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。